{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:38:18Z","timestamp":1774352298183,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,24]]},"DOI":"10.7759\/cureus.105748","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:46:01Z","timestamp":1774345561000},"source":"Crossref","is-referenced-by-count":0,"title":["Preventive Healthcare for Women in Primary Care: A Narrative Review of Updated Screening, Risk Assessment, and Counseling Recommendations"],"prefix":"10.7759","author":[{"given":"Amani","family":"Altaiam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackleen","family":"Almomani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. Breast cancer. https.\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer."},{"key":"ref2","unstructured":"World Health Organization. Cervical cancer. https.\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer."},{"key":"ref3","unstructured":"International Agency for Research on Cancer. WHO. Global Cancer Observatory. World fact sheet. 2022. https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/900-world-fact-sheet.pdf."},{"key":"ref4","unstructured":"Epidemiology of osteoporosis and fragility fractures. International Osteroporosis Foundation. https.\/\/www.osteoporosis.foundation\/facts-statistics\/epidemiology-of-osteoporosis-and-fragility-fractures."},{"key":"ref5","unstructured":"Health Resources and Services Administration. Women\u2019s Preventive Services Guidelines. https.\/\/www.hrsa.gov\/womens-guidelines."},{"key":"ref6","unstructured":"Centers for Disease Control and Prevention. Guidelines for vaccinating pregnant women. https.\/\/www.cdc.gov\/vaccines-pregnancy\/hcp\/vaccination-guidelines\/index.html."},{"key":"ref7","unstructured":"U.S. Preventive Services Task Force. Breast cancer. screening. Final recommendation statement. 2024. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/breast-cancer-screening."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.12783","article-title":"Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society","volume":"314","author":"Oeffinger KC","year":"2015","unstructured":"Oeffinger KC, Fontham ETH, Etzioni R, et al.. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015, 314:1599-1614. 10.1001\/jama.2015.12783","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005757","article-title":"Age to initiate routine breast cancer screening: ACOG clinical practice update","volume":"145","year":"2025","unstructured":"Age to initiate routine breast cancer screening. ACOG clinical practice update. Obstet Gynecol\r\n. 2025, 145:e40-4. 10.1097\/AOG.0000000000005757","journal-title":"Obstet Gynecol"},{"key":"ref10","unstructured":"National Health Service. Who breast screening is for. https.\/\/www.nhs.uk\/tests-and-treatments\/breast-screening-mammogram\/who-breast-screening-is-for\/."},{"key":"ref11","unstructured":"U.S. Preventive Services Task Force. Cervical cancer. screening. Final recommendation statement. (2018). https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/cervical-cancer-screening."},{"key":"ref12","unstructured":"American College of Obstetricians and Gynecologists. Updated cervical cancer screening guidelines. Practice Advisory. (2025). https.\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2021\/04\/updated-cervical-cancer-screening-...."},{"key":"ref13","unstructured":"American Cancer Society, screening guidelines for the prevention and early detection of cervical cancer. https.\/\/acsjournals.onlinelibrary.wiley.com\/doi\/full\/10.3322\/caac.21628."},{"key":"ref14","unstructured":"Cervical screening. programme overview. https:\/\/www.gov.uk\/guidance\/cervical-screening-programme-overview."},{"key":"ref15","unstructured":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. Second edition. (2021). https.\/\/www.who.int\/publications\/i\/item\/9789240030824."},{"key":"ref16","unstructured":"Colorectal cancer. screening. Final recommendation statement. (2021). https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/colorectal-cancer-screening."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21457","article-title":"Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society","volume":"68","author":"Wolf AM","year":"2018","unstructured":"Wolf AM, Fontham ET, Church TR, et al.. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018, 68:250-81. 10.3322\/caac.21457","journal-title":"CA Cancer J Clin"},{"key":"ref18","unstructured":"National Health Service. Bowel cancer screening programme overview. https.\/\/www.gov.uk\/guidance\/bowel-cancer-screening-programme-overview."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001122","article-title":"ACG Clinical Guidelines: Colorectal Cancer Screening 2021","volume":"116","author":"Shaukat A","year":"2021","unstructured":"Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG Clinical Guidelines: Colorectal Cancer Screening 2021. Am J Gastroenterol. 2021, 116:458-79. 10.14309\/ajg.0000000000001122","journal-title":"Am J Gastroenterol"},{"key":"ref20","unstructured":"World Health Organization. Cancer. https.\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.1117","article-title":"Screening for lung cancer: US Preventive Services Task Force recommendation statement","volume":"325","author":"Krist AH","year":"2021","unstructured":"Krist AH, Davidson KW, Mangione CM, et al.. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021, 325:962-70. 10.1001\/jama.2021.1117","journal-title":"JAMA"},{"key":"ref22","unstructured":"American Cancer Society. Lung cancer screening guidelines. https.\/\/acsjournals.onlinelibrary.wiley.com\/doi\/full\/10.3322\/caac.21811."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.151421","article-title":"Recommendations on screening for lung cancer","volume":"188","author":"Canadian Task Force on Preventive Health Care","year":"2016","unstructured":"Canadian Task Force on Preventive Health Care. Recommendations on screening for lung cancer. CMAJ. 2016, 188:425-32. 10.1503\/cmaj.151421","journal-title":"CMAJ"},{"key":"ref24","unstructured":"UK National Screening Committee. Lung cancer screening recommendation. https.\/\/view-health-screening-recommendations.service.gov.uk\/lung-cancer\/."},{"key":"ref25","unstructured":"U.S. Preventive Services Task Force. Osteoporosis to prevent fractures. screening. (2025). https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/osteoporosis-screening."},{"key":"ref26","unstructured":"Canadian Task Force on Preventive Health Care. Fragility fractures (2023). https.\/\/canadiantaskforce.ca\/guidelines\/published-guidelines\/fragility-fractures."},{"key":"ref27","unstructured":"National Osteoporosis Guideline Group. Clinical guideline for the prevention and treatment of osteoporosis. (NOGG). https.\/\/www.nogg.org.uk\/full-guideline."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.52637","article-title":"2024 Royal Australian College of General Practitioners and Healthy Bones Australia guideline for osteoporosis management and fracture prevention in postmenopausal women and men over 50 years of age","volume":"222","author":"Wong P","year":"2025","unstructured":"Wong P, Chen W, Ewald D, Girgis C, Rawlin M, Tsingos J, Waters J. 2024 Royal Australian College of General Practitioners and Healthy Bones Australia guideline for osteoporosis management and fracture prevention in postmenopausal women and men over 50 years of age . Med J Aust. 2025, 222:472-80. 10.5694\/mja2.52637","journal-title":"Med J Aust"},{"key":"ref29","unstructured":"Osteoporosis prevention, screening, and diagnosis. ACOG Clinical Practice Guideline No. 1. https.\/\/doi.org\/10.1097\/AOG.0000000000004514."},{"key":"ref30","unstructured":"Guidelines for fracture risk assessment and management of osteoporosis in postmenopausal women and men above the age of 50 in Qatar. https.\/\/doi.org\/10.1007\/s11657-024-01389-0."},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Screening for hypertension in adults. US Preventive Services Task Force reaffirmation recommendation statement. https:\/\/doi.org\/10.1001\/jama.2021.4987.","DOI":"10.1001\/jama.2021.4987"},{"key":"ref32","unstructured":"ACC\/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. https.\/\/doi.org\/10.1161\/HYP.0000000000000065."},{"key":"ref33","unstructured":"Screening for prediabetes and type 2 diabetes. US Preventive Services Task Force recommendation statement. https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2783414."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S002","article-title":"2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diabetes Care. 2025, 48:S27-49. 10.2337\/dc25-S002","journal-title":"Diabetes Care"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Prevention or delay of diabetes and associated comorbidities. Standards of care in diabetes - 2025. https:\/\/doi.org\/10.2337\/dc25-S003.","DOI":"10.2337\/dc25-S003"},{"key":"ref36","unstructured":"Statin use for the primary prevention of cardiovascular disease in adults. US Preventive Services Task Force recommendation statement. https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2795521."},{"key":"ref37","unstructured":"AHA\/ACC guideline on the management of blood cholesterol. https.\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000000625."},{"key":"ref38","unstructured":"U.S. Preventive Services Task Force-Aspirin use to prevent cardiovascular disease. recommendation statement.. https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2791399."},{"key":"ref39","unstructured":"ACC\/AHA guideline on the primary prevention of cardiovascular disease. https.\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000000678."},{"key":"ref40","unstructured":"Screening for gestational diabetes. US Preventive Services Task Force recommendation statement. https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2782858."},{"key":"ref41","unstructured":"Aspirin use to prevent preeclampsia and related morbidity and mortality. recommendation statement. https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2784499."},{"key":"ref42","unstructured":"American College of Obstetricians and Gynecologists. Low-dose aspirin use for the prevention of preeclampsia and related morbidity and mortality. (2021). https.\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2021\/12\/low-dose-aspirin-use-for-the-preve...."},{"key":"ref43","unstructured":"U.S. Preventive Services Task Force-Perinatal depression. preventive interventions. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/perinatal-depression-preventive-interventions."},{"key":"ref44","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.14081","article-title":"Screening for chlamydia and gonorrhea: recommendation statement","volume":"326","author":"US Preventive Services Task Force","year":"2021","unstructured":"US Preventive Services Task Force. Screening for chlamydia and gonorrhea: recommendation statement. JAMA. 2021, 326:949-56.","journal-title":"JAMA"},{"key":"ref45","unstructured":"US Preventive Services Task Force. Human immunodeficiency virus (HIV) infection. Screening. Final recommendation statement. (2019). https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/human-immunodeficiency-virus-hiv-infection-screening."},{"key":"ref46","unstructured":"US Preventive Services Task Force. Hepatitis C virus infection in adolescents and adults. Screening. Final recommendation statement. (2020). https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/hepatitis-c-screening."},{"key":"ref47","unstructured":"US Preventive Services Task Force. Hepatitis B virus infection in pregnant women. screening. Final recommendation statement.. (2019). https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/hepatitis-b-virus-infection-in-pregnant-women-scr...."},{"key":"ref48","article-title":"","author":"US Preventive Services Task Force. Syphilis infection during pregnancy: screening. Final recommendation statement","unstructured":"US Preventive Services Task Force. Syphilis infection during pregnancy. screening. Final recommendation statement: https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/syphilis-infection-in-pregnancy-screening."},{"key":"ref49","unstructured":"CDC. Sexually transmitted infections treatment guidelines, 2021. Screening recommendations and considerations referenced in Treatment guidelines and original sources. https.\/\/www.cdc.gov\/std\/treatment-guidelines\/screening-recommendations.htm."},{"key":"ref50","unstructured":"UK Government. National chlamydia screening programme. https.\/\/www.gov.uk\/government\/collections\/national-chlamydia-screening-programme-ncsp."},{"key":"ref51","unstructured":"National Institute for Health and Care Excellence. HIV testing. increasing uptake among people who may have undiagnosed HIV. https:\/\/www.nice.org.uk\/guidance\/ng60."},{"key":"ref52","unstructured":"National Institute for Health and Care Excellence. Hepatitis B and C testing. people at risk of infection. (2013). https:\/\/www.nice.org.uk\/guidance\/ph43."},{"key":"ref53","unstructured":"UK Government. Infectious diseases in pregnancy screening (IDPS). programme overview. https:\/\/www.gov.uk\/guidance\/infectious-diseases-in-pregnancy-screening-programme-overview."},{"key":"ref54","unstructured":"WHO. Laboratory and point-of-care diagnostic testing for sexually transmitted infections, including HIV. https.\/\/www.who.int\/publications\/i\/item\/9789240077089."},{"key":"ref55","unstructured":"WHO. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring. recommendations for a public health approach. (2021). https:\/\/www.who.int\/publications\/i\/item\/9789240031593."},{"key":"ref56","unstructured":"WHO. Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. (2016). https.\/\/www.who.int\/publications\/i\/item\/9789241549615."},{"key":"ref57","unstructured":"WHO. Elimination of mother-to-child transmission of HIV, syphilis and hepatitis B. https.\/\/www.who.int\/initiatives\/triple-elimination-initiative-of-mother-to-child-transmission-of-hiv-syphilis-and-hep...."},{"key":"ref58","unstructured":"WHO. WHO guideline on syphilis screening and treatment for pregnant women. (2017). https.\/\/www.who.int\/publications\/i\/item\/9789241550093."},{"key":"ref59","unstructured":"U.S. Preventive Services Task Force.  Depression and suicide risk in adults. screening. (2023). https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/screening-depression-suicide-risk-adults."},{"key":"ref60","unstructured":"U.S. Preventive Services Task Force. Anxiety disorders in adults. screening. (2023). https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/anxiety-adults-screening."},{"key":"ref61","unstructured":"U.S. Preventive Services Task Force. Intimate partner violence and caregiver abuse of older or vulnerable adults. screening. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/intimate-partner-violence-and-abuse-of-elderly-an...."},{"key":"ref62","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.rr7305a1","article-title":"Prevention and control of seasonal influenza with vaccines: Recommendations of the advisory committee on immunization practices - United States, 2024-25 influenza season","volume":"73","author":"Grohskopf LA","year":"2024","unstructured":"Grohskopf LA, Ferdinands JM, Blanton MP, Broder KR, Loehr J. Prevention and control of seasonal influenza with vaccines: Recommendations of the advisory committee on immunization practices - United States, 2024-25 influenza season. MMWR Recommendations and Reports. 2024, 73:1-25.","journal-title":"MMWR Recommendations and Reports"},{"key":"ref63","article-title":"Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: Updated recommendations of the Advisory Committee on Immunization Practices - United States, 2019","volume":"69","author":"Havers FP","year":"2020","unstructured":"Havers FP, Moro PL, Hunter P, Hariri S, Berstein H. Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: Updated recommendations of the Advisory Committee on Immunization Practices - United States, 2019. MMWR Weekly. 2020, 69:77-83.","journal-title":"MMWR Weekly"},{"key":"ref64","unstructured":"CDC. Interim clinical considerations for use of COVID-19 vaccines in the United States. (2025). https.\/\/www.cdc.gov\/covid\/hcp\/vaccine-considerations\/index.html."},{"key":"ref65","article-title":"Use of the Pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023","volume":"72","author":"Fleming-Dutra KE","year":"2023","unstructured":"Fleming-Dutra KE, Jones JM, Roper LE, et al.. Use of the Pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Weekly. 2023, 72:1115-22.","journal-title":"MMWR Weekly"},{"key":"ref66","unstructured":"CDC. Adult immunization schedule notes. (2025). https.\/\/www.cdc.gov\/vaccines\/hcp\/imz-schedules\/adult-notes.html."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/452987-preventive-healthcare-for-women-in-primary-care-a-narrative-review-of-updated-screening-risk-assessment-and-counseling-recommendations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:46:55Z","timestamp":1774345615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/452987-preventive-healthcare-for-women-in-primary-care-a-narrative-review-of-updated-screening-risk-assessment-and-counseling-recommendations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":66,"URL":"https:\/\/doi.org\/10.7759\/cureus.105748","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,24]]}}}